Absolute eosinophil count (AEC) is a blood test result that tells you how many eosinophils, a specific type of white blood cell, are circulating in each microliter of your blood. In healthy adults, that number generally falls between about 100 and 500 cells per microliter. Counts above roughly 500 are considered elevated, and counts that stay above 1,500 raise concern for serious underlying conditions. If you have just received lab results and noticed an unusual eosinophil number, the count itself is a clue rather than a diagnosis, but the direction and magnitude of the abnormality can point your doctor toward specific causes worth investigating.
What Eosinophils Actually Do
Eosinophils are one of five types of white blood cells, and they make up only a small fraction of the total, typically around 1 to 4 percent. Despite their low numbers, they punch above their weight. They carry granules packed with potent proteins that can kill parasites, break down foreign material, and modulate inflammation. Research has confirmed that these granule proteins play roles in asthma, allergic diseases, parasitic infections, and hypereosinophilic syndromes, while also shaping broader immune functions including tissue repair and the maintenance of normal tissue balance.1PubMed Central. Eosinophil granule proteins: form and function More recently, researchers have recognized that eosinophils also participate in regulating local immunity and remodeling injured tissue, functions sometimes grouped under the nickname “LIAR hypothesis” (Local Immunity And/or Remodeling/Repair).2PubMed Central. Considerations on the evolutionary biology and functions of eosinophils: what the “haeckel”?
The evolutionary story behind eosinophils is surprisingly ancient. The enzyme that gives them their characteristic staining behavior, eosinophil peroxidase, appears to have diverged from a related enzyme in other white blood cells roughly 60 to 70 million years ago.3PubMed Central. Considerations on the evolutionary biology and functions of eosinophils: what the “haeckel”? Their persistence across so many species suggests they serve essential functions, though interestingly, mice bred without eosinophils do not show obvious health problems under lab conditions, and humans treated with drugs that deplete eosinophils can still carry pregnancies to term. This paradox keeps researchers debating exactly how indispensable the cell truly is in modern humans.
Common Causes of a High Count
The most frequent reason for a mildly elevated AEC is an allergic condition. Hay fever, eczema, drug reactions, and especially asthma can all push the count above the normal ceiling. In asthma, eosinophils are central players: they migrate into airway tissue, release inflammatory mediators, and contribute to the swelling and mucus that make breathing difficult. One classic study found that patients with active bronchial asthma who were not on steroids had counts consistently above 350 cells per cubic millimeter, while untreated healthy subjects averaged about 122.4New England Journal of Medicine. Total eosinophil counts in the management of bronchial asthma The cytokine interleukin-5 (IL-5) is the primary chemical signal behind this buildup; it drives eosinophil production in the bone marrow, keeps them alive longer, and activates them once they reach inflamed tissue.5PubMed Central. Interleukin-5 in the Pathophysiology of Severe Asthma
Parasitic infections, particularly worm (helminth) infections, are another well-known trigger. When a parasite invades through skin, lung, or intestinal barriers, the damaged tissue releases alarm signals that ramp up the same IL-5-driven pathway. The result is a surge of eosinophils in both the bloodstream and the infected tissues. Other cytokines including IL-4 and IL-13 also contribute, orchestrating the recruitment of eosinophils to where the parasites are.6Journal of Leukocyte Biology. Eosinophils as modulators of host defense during parasitic, fungal, bacterial, and viral infections In parts of the world where soil-transmitted helminths are common, parasitic infection is actually the leading cause of eosinophilia, far outpacing allergies.
When Eosinophilia Becomes Dangerous
Mild elevation is common and usually manageable. The real concern begins when counts climb above 1,500 cells per microliter and stay there. This sustained high count defines what doctors call hypereosinophilic syndrome (HES), a group of conditions in which the sheer number of activated eosinophils begins damaging organs. The heart is one of the most vulnerable targets. Eosinophils can infiltrate heart tissue, triggering inflammation and eventually scarring that impairs the heart’s ability to pump.7PubMed Central. Cardiovascular manifestations of hypereosinophilic syndromes The lungs, skin, and nervous system can also be affected.
In rare cases, an extremely high eosinophil count signals a blood cancer. Chronic eosinophilic leukemia, for example, is a myeloproliferative disorder in which a genetic rearrangement drives uncontrolled eosinophil production. One well-studied subtype involves a fusion gene called FIP1L1-PDGFRα. Fortunately, this particular variant responds dramatically to the targeted drug imatinib, which can bring the count down rapidly and prevent further organ damage from eosinophil infiltration.8PubMed Central. Chronic Eosinophilic Leukemia Positive for FIP1L1-PDGFRa
Eosinophils and the Gut
Eosinophilic gastrointestinal diseases are a growing area of interest, and blood eosinophil counts are part of how doctors monitor them. Eosinophilic esophagitis (EoE), for instance, causes eosinophils to accumulate in the lining of the esophagus, leading to difficulty swallowing and food impaction. Researchers have found that the absolute eosinophil count in the blood correlates with the density of eosinophils found in esophageal biopsies. In one study, patients with active EoE had a mean AEC of about 440 cells per microliter compared with 140 in controls.9Clinical Gastroenterology and Hepatology. Potential of Blood Eosinophils, Eosinophil-Derived Neurotoxin, and Eotaxin-3 as Biomarkers of Eosinophilic Esophagitis That difference matters clinically because the blood test is far less invasive than an endoscopy with biopsy, so tracking the AEC between scopes can give doctors a rough gauge of disease activity.
Eosinophils in Autoimmune Disease
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is an autoimmune condition that inflames blood vessels and tends to affect people who already have asthma. The AEC is not just a diagnostic marker here; its magnitude appears to predict which complications a patient will develop. A study of EGPA patients found that higher eosinophil counts were positively associated with peripheral nervous system involvement. No patients with counts below about 1,150 cells per microliter showed nerve damage at all, making the AEC a practical gauge for clinical complexity.10PubMed Central. Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience
EGPA also carries a heightened risk of blood clots, and eosinophil counts may partly explain why. Research has shown that EGPA patients form denser, harder-to-dissolve blood clots compared with healthy people, and the absolute eosinophil count independently predicted how compact those clots were.11PLOS ONE. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia In other words, the higher the count, the more the blood’s clotting system tilted toward dangerous clot formation. This connection between eosinophils and clotting behavior is still being explored, but it adds another reason to take persistent eosinophilia seriously.
What a Low Count Can Signal
While elevated eosinophils grab most of the attention, a very low or absent count, sometimes called eosinopenia, also carries meaning. The most common cause is straightforward: corticosteroid use. Steroids like prednisone cause eosinophils to leave the bloodstream and retreat into tissues or undergo programmed cell death. Studies routinely exclude steroid users from eosinophil research precisely because the effect is so reliable and pronounced.12Clinical Epidemiology and Global Health. Absolute eosinophil count as a diagnostic and prognostic marker compared to C- reactive protein and Procalcitonin in patients with sepsis One earlier study demonstrated that healthy subjects on prednisone had average counts of only about 43 cells per cubic millimeter, compared with 122 in untreated subjects.13New England Journal of Medicine. Total eosinophil counts in the management of bronchial asthma
Beyond steroids, acute infections, especially bacterial sepsis, can suppress eosinophils. The body’s stress response floods the bloodstream with cortisol and adrenaline, both of which push eosinophils out of circulation. Cushing’s syndrome, alcohol intoxication, and severe physical stress produce similar effects through the same cortisol pathway. If your AEC comes back near zero and you are not taking steroids, your doctor will likely look for signs of acute infection or significant physiological stress.
Factors That Can Skew Your Results
Eosinophil counts are not as rock-solid as they might seem on a lab printout. Several factors can shift the number you see without any real change in your health.
Time of day matters. Eosinophil levels follow a circadian rhythm, peaking at night and dipping in the morning, driven partly by the daily rise and fall of cortisol and adrenaline. In asthma patients, circulating eosinophil numbers at nighttime correlated with both the frequency of nighttime asthma episodes and the degree of airflow obstruction.14American Journal of Respiratory and Critical Care Medicine. Relationship Of Plasma Epinephrine And Circulating Eosinophils To Nocturnal Asthma A blood draw at 8 a.m. and another at 10 p.m. on the same day can yield meaningfully different numbers in the same person. If your doctor is tracking your eosinophils over time, getting blood drawn at roughly the same time of day each visit helps reduce noise.
Lab handling is another variable. A comparative study of four hematology analyzers found that all gave comparable eosinophil measurements on fresh blood drawn the same day, but by 24 hours after collection, significant differences emerged depending on which machine was used and at what temperature the sample had been stored. Eosinophils were the cell type most affected by these delays.15PubMed Central. A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors Another study confirmed this pattern, showing that eosinophil and lymphocyte counts decreased over time when blood was stored at refrigerator temperatures, and that different analyzer brands showed different stability profiles, with some cell types remaining stable for only about four hours.16PubMed. Stability of hematological analytes depends on the hematology analyser used: a stability study with Bayer Advia 120, Beckman Coulter LH 750 and Sysmex XE 2100
Even comparing results between labs can introduce error. A study that sent samples from the same 62 subjects to ten different laboratories found generally good agreement, but eosinophil counts tended to be higher at regional labs than at the central reference lab. The gap widened at higher counts, which is exactly the range where clinical decisions about treatment thresholds are made. Rounding practices also varied: some labs reported to one decimal place and others to two, which introduced further discrepancy.17Annals of the American Thoracic Society. A Comprehensive Analysis of the Stability of Blood Eosinophil Levels The practical takeaway is that a single borderline eosinophil count should not trigger alarm. Repeat testing, ideally at the same lab with the same timing, gives a much more reliable picture.
Eosinophil Counts in Newborns
If you are reading your infant’s lab results, adult reference ranges do not apply. Newborn eosinophil counts are naturally higher. A large study analyzing over 63,000 records established that at 40 weeks of gestation, the normal range on the day of birth is about 140 to 1,300 cells per microliter, with a mean of 550.18PubMed. Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period defined from over 63 000 records in a multihospital health-care system That mean value is already above what many adults would consider normal. Premature babies tend to have lower counts at birth, with the mean rising in a roughly linear fashion between 22 and 42 weeks of gestation. Over the first four weeks of life, average counts stay relatively stable, with a slight increase in the upper limit by week four. A neonatologist looking at a count of 800 in a full-term newborn, in other words, is not concerned, even though the same number in an adult would prompt further investigation.
Eosinophils as a Biomarker in Cancer Immunotherapy
An emerging use for the AEC is as a predictor of how well certain cancer patients will respond to immunotherapy. In non-small cell lung cancer, studies have found that patients with higher baseline eosinophil counts before starting immune checkpoint inhibitors tend to fare better. One study reported that patients with AEC at or above 130 cells per microliter had response rates of about 64 percent compared with roughly 36 percent in those below that threshold. Progression-free survival was also substantially longer in the higher-count group.19PubMed. Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy A larger, more recent analysis confirmed this pattern: patients with high baseline AEC had a median progression-free survival of about 24 months versus 12 months, and overall survival had not even been reached in the high-AEC group at the time of analysis. Multivariable modeling confirmed that high AEC was an independent favorable factor, not just a proxy for other characteristics like tumor stage.20PubMed Central. The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis
The relationship is not entirely straightforward, though. The same study that found improved survival also found that high baseline AEC was associated with a greater risk of a specific side effect: immune checkpoint inhibitor-related pneumonitis, a potentially dangerous lung inflammation.21PubMed Central. The dual role of baseline absolute eosinophil count in non-small cell lung cancer immunotherapy: a biomarker for enhanced efficacy and elevated risk of immune checkpoint inhibitor-related pneumonitis So a higher eosinophil count at baseline may reflect a more active immune system that both fights the cancer more effectively and overreacts to the drug in the lungs. Oncologists are watching this research closely because the AEC is cheap and already part of routine bloodwork, making it an attractive addition to the clinical toolbox if the association holds up in further trials.
Treatments That Directly Target Eosinophils
For decades, the main tools for lowering eosinophils were corticosteroids and treating whatever underlying condition was driving the count up. That changed with the arrival of biologic drugs designed specifically to interfere with eosinophil biology. Mepolizumab, the first to reach the market for severe eosinophilic asthma, works by binding to IL-5, the cytokine most responsible for eosinophil survival and activation.22PubMed Central. From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases By neutralizing IL-5, mepolizumab reduces the signal that tells the bone marrow to keep making eosinophils, and the blood count drops over weeks.
Benralizumab takes a more aggressive approach. Instead of just blocking the IL-5 signal, it binds to the IL-5 receptor on the surface of eosinophils themselves, tagging the cells for destruction by natural killer cells. The result is faster and more complete depletion. A head-to-head comparison found that benralizumab caused rapid, near-complete elimination of blood eosinophils with an onset similar to that seen with oral prednisolone, and the count at 30 days was significantly lower after benralizumab compared with mepolizumab.23PubMed Central. Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma In a real-world comparison, all patients on benralizumab reached undetectable eosinophil levels, compared with about a third of those on mepolizumab.24PubMed Central. Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts Both drugs significantly reduced counts; the choice between them often depends on how quickly and completely a patient’s disease demands eosinophil depletion.
Beyond the IL-5 pathway, researchers are investigating Siglec-8, a receptor found almost exclusively on eosinophils, mast cells, and basophils. Antibodies that cross-link Siglec-8 on the eosinophil surface trigger the cell to self-destruct through a programmed death process that even IL-5 cannot override. In lab experiments, IL-5 and similar survival signals not only failed to block this death pathway but actually made eosinophils more sensitive to it.25PubMed. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis In a mouse model of eosinophilic gastrointestinal disease, anti-Siglec-8 antibodies significantly reduced eosinophils in the stomach, small intestine, and blood.26The Journal of Clinical Investigation. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis An anti-Siglec-8 antibody also depleted eosinophils in human sputum samples from asthma patients.27PubMed Central. An anti-Siglec-8 Antibody Depletes Sputum Eosinophils from Asthmatic Subjects and Inhibits Lung Mast Cells This approach is still earlier in development than the IL-5-targeting drugs, but it represents a fundamentally different strategy: rather than cutting off the supply of eosinophils, it triggers the cells that already exist to destroy themselves, even in the inflamed tissue where they are doing the most harm.